Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02889133 · ClinicalTrials.gov registry record · NA
Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT02889133 is a NA study that has completed, run by Columbia University. The registered enrollment target is 79 participants.
The verdict
NCT02889133, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Primary Hypothesis * The 24-hour post-transfusion RBC recovery of units obtained from donors exhibiting iron-deficient erythropoiesis will not meet FDA standards for clinical use. * The 24-hour post-transfusion RBC recovery of units obtained after intravenous iron repletion will improve significantly and will meet FDA standards for clinical use.
Interventions
- DRUG Saline
- PROCEDURE Blood Donation
- DRUG Iron-dextran
- PROCEDURE 24-hour PTR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02889133
The ClinicalTrials.gov registry entry for NCT02889133 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Saline is the first listed.
NCT02889133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02889133 about?
NCT02889133 is a clinical study titled "Donor Iron Deficiency Study - Red Blood Cells From Iron-deficient Donors: Recovery and Storage Quality". Primary Hypothesis * The 24-hour post-transfusion RBC recovery of units obtained from donors exhibiting iron-deficient erythropoiesis will not meet FDA standards for clinical use. * The 24-hour post-transfusion RBC recovery of units obtained after intravenous iron repletion will improve significant...
What is the current status of trial NCT02889133?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2017-01. Estimated completion is 2021-10-05.
What interventions are being tested in trial NCT02889133?
The interventions under investigation include: Saline (DRUG), Blood Donation (PROCEDURE), Iron-dextran (DRUG), 24-hour PTR (PROCEDURE).
Who is sponsoring clinical trial NCT02889133?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.